Skip to main content

GALT

Galectin Therapeutics Inc

Company with tickers: GALT

CIK
1133416
CUSIP
363225202
Shares Outstanding
65,856,898
13F Activity (30d)
82 filings 80 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 100
Total Value: $43,159,960
Total Shares: 15,469,539
Showing 1–100 of 105 holdings by value · page 1 of 2

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 100 13F filers · Δ vs Dec 31, 2025
Top Holder
12.7%
Jun 2023 → Mar 2026 · range 12.7% – 36.1%
−5.8 pts
Top 5
40.0%
Jun 2023 → Mar 2026 · range 40.0% – 75.7%
−5.8 pts
Top 10
61.9%
Jun 2023 → Mar 2026 · range 61.9% – 85.9%
−1.9 pts
HHI
499
Jun 2023 → Mar 2026 · range 499 – 1,907
Broadly held −151

Quarterly Activity

vs Dec 31, 2025
New
20
Increased
32
Decreased
24
Sold Out
18
Unchanged
24
Holder count: +2
Institutional value: -16.1%
Shares held: +25.1%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 105
Export CSV
Holder Value (USD) % of 13F Shares Open